207 related articles for article (PubMed ID: 19155314)
1. Multidrug resistance decreases with mutations of melanosomal regulatory genes.
Xie T; Nguyen T; Hupe M; Wei ML
Cancer Res; 2009 Feb; 69(3):992-9. PubMed ID: 19155314
[TBL] [Abstract][Full Text] [Related]
2. Melanosomal pH controls rate of melanogenesis, eumelanin/phaeomelanin ratio and melanosome maturation in melanocytes and melanoma cells.
Ancans J; Tobin DJ; Hoogduijn MJ; Smit NP; Wakamatsu K; Thody AJ
Exp Cell Res; 2001 Aug; 268(1):26-35. PubMed ID: 11461115
[TBL] [Abstract][Full Text] [Related]
3. Targeting protein-trafficking pathways alters melanoma treatment sensitivity.
Huang ZM; Chinen M; Chang PJ; Xie T; Zhong L; Demetriou S; Patel MP; Scherzer R; Sviderskaya EV; Bennett DC; Millhauser GL; Oh DH; Cleaver JE; Wei ML
Proc Natl Acad Sci U S A; 2012 Jan; 109(2):553-8. PubMed ID: 22203954
[TBL] [Abstract][Full Text] [Related]
4. Glycoprotein nonmetastatic melanoma protein b, a melanocytic cell marker, is a melanosome-specific and proteolytically released protein.
Hoashi T; Sato S; Yamaguchi Y; Passeron T; Tamaki K; Hearing VJ
FASEB J; 2010 May; 24(5):1616-29. PubMed ID: 20056711
[TBL] [Abstract][Full Text] [Related]
5. Involvement of dynein and spectrin with early melanosome transport and melanosomal protein trafficking.
Watabe H; Valencia JC; Le Pape E; Yamaguchi Y; Nakamura M; Rouzaud F; Hoashi T; Kawa Y; Mizoguchi M; Hearing VJ
J Invest Dermatol; 2008 Jan; 128(1):162-74. PubMed ID: 17687388
[TBL] [Abstract][Full Text] [Related]
6. Melanosomal sequestration of cytotoxic drugs contributes to the intractability of malignant melanomas.
Chen KG; Valencia JC; Lai B; Zhang G; Paterson JK; Rouzaud F; Berens W; Wincovitch SM; Garfield SH; Leapman RD; Hearing VJ; Gottesman MM
Proc Natl Acad Sci U S A; 2006 Jun; 103(26):9903-7. PubMed ID: 16777967
[TBL] [Abstract][Full Text] [Related]
7. Influence of melanosome dynamics on melanoma drug sensitivity.
Chen KG; Leapman RD; Zhang G; Lai B; Valencia JC; Cardarelli CO; Vieira WD; Hearing VJ; Gottesman MM
J Natl Cancer Inst; 2009 Sep; 101(18):1259-71. PubMed ID: 19704071
[TBL] [Abstract][Full Text] [Related]
8. The etiology of oculocutaneous albinism (OCA) type II: the pink protein modulates the processing and transport of tyrosinase.
Toyofuku K; Valencia JC; Kushimoto T; Costin GE; Virador VM; Vieira WD; Ferrans VJ; Hearing VJ
Pigment Cell Res; 2002 Jun; 15(3):217-24. PubMed ID: 12028586
[TBL] [Abstract][Full Text] [Related]
9. ADAM protease inhibitors reduce melanogenesis by regulating PMEL17 processing in human melanocytes.
Kawaguchi M; Hozumi Y; Suzuki T
J Dermatol Sci; 2015 May; 78(2):133-42. PubMed ID: 25818872
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta1 mediates hypopigmentation of B16 mouse melanoma cells by inhibition of melanin formation and melanosome maturation.
Martínez-Esparza M; Ferrer C; Castells MT; García-Borrón JC; Zuasti A
Int J Biochem Cell Biol; 2001 Oct; 33(10):971-83. PubMed ID: 11470231
[TBL] [Abstract][Full Text] [Related]
11. Subcellular distribution of tyrosinase and tyrosinase-related protein-1: implications for melanosomal biogenesis.
Orlow SJ; Boissy RE; Moran DJ; Pifko-Hirst S
J Invest Dermatol; 1993 Jan; 100(1):55-64. PubMed ID: 8423398
[TBL] [Abstract][Full Text] [Related]
12. Disruption of melanosome transport in melanocytes treated with theophylline causes their degradation by autophagy.
Katsuyama Y; Taira N; Yoshioka M; Okano Y; Masaki H
Biochem Biophys Res Commun; 2017 Mar; 485(1):126-130. PubMed ID: 28188783
[TBL] [Abstract][Full Text] [Related]
13. Rab7 regulates maturation of melanosomal matrix protein gp100/Pmel17/Silv.
Kawakami A; Sakane F; Imai S; Yasuda S; Kai M; Kanoh H; Jin HY; Hirosaki K; Yamashita T; Fisher DE; Jimbow K
J Invest Dermatol; 2008 Jan; 128(1):143-50. PubMed ID: 17625594
[TBL] [Abstract][Full Text] [Related]
14. Dual loss of ER export and endocytic signals with altered melanosome morphology in the silver mutation of Pmel17.
Theos AC; Berson JF; Theos SC; Herman KE; Harper DC; Tenza D; Sviderskaya EV; Lamoreux ML; Bennett DC; Raposo G; Marks MS
Mol Biol Cell; 2006 Aug; 17(8):3598-612. PubMed ID: 16760433
[TBL] [Abstract][Full Text] [Related]
15. A mutation within the transmembrane domain of melanosomal protein Silver (Pmel17) changes lumenal fragment interactions.
Kuliawat R; Santambrogio L
Eur J Cell Biol; 2009 Nov; 88(11):653-67. PubMed ID: 19679373
[TBL] [Abstract][Full Text] [Related]
16. The PIKfyve complex regulates the early melanosome homeostasis required for physiological amyloid formation.
Bissig C; Croisé P; Heiligenstein X; Hurbain I; Lenk GM; Kaufman E; Sannerud R; Annaert W; Meisler MH; Weisman LS; Raposo G; van Niel G
J Cell Sci; 2019 Feb; 132(5):. PubMed ID: 30709920
[TBL] [Abstract][Full Text] [Related]
17. Assembly, target-signaling and intracellular transport of tyrosinase gene family proteins in the initial stage of melanosome biogenesis.
Jimbow K; Park JS; Kato F; Hirosaki K; Toyofuku K; Hua C; Yamashita T
Pigment Cell Res; 2000 Aug; 13(4):222-9. PubMed ID: 10952389
[TBL] [Abstract][Full Text] [Related]
18. Endoplasmic reticulum export, subcellular distribution, and fibril formation by Pmel17 require an intact N-terminal domain junction.
Leonhardt RM; Vigneron N; Rahner C; Van den Eynde BJ; Cresswell P
J Biol Chem; 2010 May; 285(21):16166-83. PubMed ID: 20231267
[TBL] [Abstract][Full Text] [Related]
19. Epitope mapping of the melanosomal matrix protein gp100 (PMEL17): rapid processing in the endoplasmic reticulum and glycosylation in the early Golgi compartment.
Yasumoto K; Watabe H; Valencia JC; Kushimoto T; Kobayashi T; Appella E; Hearing VJ
J Biol Chem; 2004 Jul; 279(27):28330-8. PubMed ID: 15096515
[TBL] [Abstract][Full Text] [Related]
20. [Toll-like receptor 4 activation inhibits melanogenesis in melanocytes].
Sun L; Sun J; Huo X; Li Y; Li Y; Xie X; Hu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Nov; 32(11):1466-1470. PubMed ID: 27774936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
